Adenosine transport, erythrocyte deformability and microvascular dysfunction: An unrecognized potential role for dipyridamole therapy

Clinical Hemorheology and Microcirculation

Volumn 44, Issue 3, 2010, Pages 193-205

  Bhavsar, Jignesh ^a   Rosenson, Robert S ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ATORVASTATIN; DIPYRIDAMOLE; HYDROGEN PEROXIDE; HYPOXANTHINE; NITRIC OXIDE SYNTHASE; XANTHINE OXIDASE;

ACUTE HEART INFARCTION; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD VESSEL DIAMETER; BLOOD VISCOSITY; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CELL MEMBRANE FLUIDITY; CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; LOW DRUG DOSE; MICROANGIOPATHY; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; REPERFUSION INJURY; RISK REDUCTION; SHEAR STRESS; STROKE; THORAX PAIN; THROMBOCYTE AGGREGATION; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VASCULAR RESISTANCE; BLOOD; DRUG EFFECTS; ERYTHROCYTE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY;

ADENOSINE; BLOOD VISCOSITY; DIPYRIDAMOLE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

EID: 77954101674     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1274     Document Type: Conference Paper

References (103)

1. M. Akhtar, K. Ordovas, A. Martin, C.B. Higgins and A.D. Michaels, Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy, Congest Heart Fail 13 (2007), 130-135.
2. A. Al-Bahrani, S. Taha, H. Shaath and M. Bakhiet, TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents, Curr Neurovasc Res 4 (2007), 31-37.
3. G. Ambrosio, H.F. Weisman, J.A. Mannisi and L.C. Becker, Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow, Circulation 80 (1989), 1846-1861.
4. R.B. Ami, G. Barshtein, D. Zeltser, Y. Goldberg, I. Shapira, A. Roth, G. Keren, H. Miller, V. Prochorov, A. Eldor, S. Berliner and S. Yedgar, Parameters of red blood cell aggregation as correlates of the inflammatory state, Am J Physiol Heart Circ Physiol 280 (2001), H1982-H1988.
5. X. An, M.C. Lecomte, J.A. Chasis, N. Mohandas andW. Gratzer, Shear-response of the spectrin dimer-tetramer equilibrium in the red blood cell membrane, J Biol Chem 277 (2002), 31796-31800.
6. J.P. Barras, Blood rheology - general review, Bibl Haematol 33 (1969), 277-297.
7. W. Barth, Viscometry in relation to serum globulins, in: Serum Proteins and Dyslipoproteinemias, W. Saunderman, ed, Lippincott, Philadelphia, 1964, 102-108.
8. G. Barshtein, R. Ben-Ami and S. Yedgar, Role of red blood cell flow behaviour in hemodynamics and hemostasis, Expert Rev Cardiovasc Ther 5 (2007), 743-752.
9. O.K. Baskurt and H.J. Meiselman, Blood rheology and hemodynamics, Semin Thromb Hemost 29 (2003), 435-450.
10. O.K. Baskurt and H.J. Meiselman, RBC aggregation: More important than RBC adhesion to endothelial cells as a determinant of in vivo blood flow in health and disease, Microcirculation 15 (2008), 585-590.
11. O.K. Baskurt, A. Temiz and H.J. Meiselman, Effect of superoxide anions on red blood cell rheologic properties, Free Radic Biol Med 24 (1998), 102-110.
12. G.F. Baxter, M.S. Marber, V.C. Patel and D.M. Yellon, Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning, Circulation 90 (1994), 2993-3000.
13. G.R. Bergfeld and T. Forrester, Release of atp from human erythrocytes in response to a brief period of hypoxia and hypercapnia, Cardiovasc Res 26 (1992), 40-47.
14. R.M. Bell and D.M. Yellon, Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway, J Am Coll Cardiol 41 (2003), 508-515.
15. V. Bennett, The spectrin-actin junction of erythrocyte membrane skeletons, Biochim Biophys Acta 988 (1989), 107-121.
16. E. Braunwald and R.A. Kloner, Myocardial reperfusion: A double-edged sword? J Clin Invest 76 (1985), 1713-1719.
17. G.E. Burch and N.P. DePasquale, Hematocrit, viscosity and coronary blood flow, Dis Chest 48 (1965), 225-232.
18. R.C. Bruch and W.S. Thayer, Differential effect of lipid peroxidation on membrane fluidity as determined by electron spin resonance probes, Biochim Biophys Acta 733 (1983), 216-222.
19. S. Chakrabarti, O. Vitseva, D. Iyu, S. Varghese and J.E. Freedman, The effect of dipyridamole on vascular cell-derived reactive oxygen species, J Pharmacol Exp Ther 315 (2005), 494-500.
20. M. Chello, P. Mastroroberto, E. Malta, F. Cirillo andV. Celi, Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery, Ann Thorac Surg 67 (1999), 1277-1282.
21. J. Danesh, R. Collins, R. Peto and G.D. Lowe, Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease, Eur Heart J 21 (2000), 515-520.
22. C.E. Darling, P.B. Solari, C.S. Smith, M.I. Furman and K. Przyklenk, 'Postconditioning' the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection, Basic Res Cardiol 102 (2007), 274-278.
23. D.V. DeFily and W.M. Chilian, Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury, Am J Physiol 265 (1993), H700-H706.
24. H.C. Diener, L. Cunha, C. Forbes, J. Sivenius, P. Smets and A. Lowenthal, European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke, J Neurol Sci 143 (1996), 1-13.
25. D.E. Discher and P. Carl, New insights into red cell network structure, elasticity, and spectrin unfolding a current review, Cell Mol Biol Lett 6 (2001), 593-606.
26. C.A. Efthymiou, M.M. Mocanu and D.M. Yellon, Atorvastatin and myocardial reperfusion injury: New pleiotropic effect implicating multiple prosurvival signaling, J Cardiovasc Pharmacol 45 (2005), 247-252.
27. R. Engler, Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia, Fed Proc 46 (1987), 2407-2412.
28. R.L. Engler, M.D. Dahlgren, D.D. Morris, M.A. Peterson and G.W. Schmid-Schonbein, Role of leukocytes in response to acute myocardial ischemia and reflow in dogs, Am J Physiol 251 (1986), H314-H323.
29. V.M. Figueredo, I. Diamond, H.Z. Zhou and S.A. Camacho, Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury, Am J Physiol 277 (1999), H2091-H2097.
30. C.A. Finch and C. Lenfant, Oxygen transport in man, N Engl J Med 286 (1972), 407-415.
31. M.B. Forman, D.W. Puett and R. Virmani, Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and therapeutic implications, J Am Coll Cardiol 13 (1989), 450-459.
32. M.B. Forman, R. Virmani and D.W. Puett, Mechanisms and therapy of myocardial reperfusion injury, Circulation 81 (1990), 69-78.
33. S. Glagov, C. Zarins, D.P. Giddens and D.N. Ku, Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries, Arch Pathol Lab Med 112 (1988), 1018-1031.
34. R. Glaser, Mechanisms of electromechanical coupling in membranes demonstrated by transmembrane potentialdependent shape transformation of human erythrocytes, Bioelectrochem Bioenerg 30 (1993), 103-109.
35. B.D. Goldstein, M.G. Rozen and M.A. Amoruso, Relation of fluorescence in lipid-containing red cell membrane extracts to in vivo lipid peroxidation, J Lab Clin Med 93 (1979), 687-694.
36. R.J. Gordon, G.K. Snyder, H. Tritel andW.J. Taylor, Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia, Am Heart J 87 (1974), 175-182.
37. N.S. Gov and S.A. Safran, Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects, Biophys J 88 (2005), 1859-1874.
38. C.B. Granger, Adenosine for myocardial protection in acute myocardial infarction, Am J Cardiol 79 (1997), 44-48.
39. P. Gresele, J. Arnout, H. Deckmyn and J. Vermylen, Mechanism of the antiplatelet action of dipyridamole in whole blood: Modulation of adenosine concentration and activity, Thromb Haemost 55 (1986), 12-18.
40. G.J. Gross and J.A. Auchampach, Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs, Circ Res 70 (1992), 223-233.
41. G.J. Grover, P.G. Sleph and S. Dzwonczyk, Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors, Circulation 86 (1992), 1310-1316.
42. P.H. Halkes, J. van Gijn, L.J. Kappelle, P.J. Koudstaal and A. Algra, Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (esprit): Randomised controlled trial, Lancet 367 (2006), 1665-1673.
43. K. Hata, P. Whittaker, R.A. Kloner and K. Przyklenk, Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: Role of adenosine, Circulation 97 (1998), 692-702.
44. D.J. Hausenloy and D.M. Yellon, New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the reperfusion injury salvage kinase (risk)-pathway, Cardiovasc Res 61 (2004), 448-460.
45. U.E. Heidland, M.P. Heintzen, C.J. Michel and B.E. Strauer, Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning, Coron Artery Dis 11 (2000), 607-613.
46. U.E Heidland, M.P. Heintzen, B. Schwartzkopff and B.E. Strauer, Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine, Am Heart J 140 (2000), 813-820.
47. H. Ito,Y.Taniyama, K. Iwakura, N. Nishikawa,T. Masuyama,T.Kuzuya, M. Hori,Y. Higashino, K. Fujii andT. Minamino, Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction, J Am Coll Cardiol 33 (1999), 654-660.
48. L. Iuliano, A. Ghiselli, C. Alessandri, M.S. Bonavita and F. Violi, Superoxide anion scavenging property of dipyridamole, Thromb Haemost 61 (1989), 149.
49. S.K. Jain, The neonatal erythrocyte and its oxidative susceptibility, Semin Hematol 26 (1989), 286-300.
50. H. Kanatsuka, K.G. Lamping, C.L. Eastham, K.C. Dellsperger and M.L. Marcus, Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance, Circ Res 65 (1989), 1296-1305.
51. D.K. Kaul, A. Koshkaryev, G. Artmann, G. Barshtein and S. Yedgar, Additive effect of red blood cell rigidity and adherence to endothelial cells in inducing vascular resistance, Am J Physiol Heart Circ Physiol 295 (2008), H1788-1793.
52. K. Kensey and Y. Cho, The Origin of Atherosclerosis: An Introduction to Hemodynamics, Emerald Pademelon Press, Haddonfield, NJ, 2002.
53. G.E Kirsch, J. Codina, L. Birnbaumer and A.M. Brown, Coupling of ATP-sensitive k+ channels to A1 receptors by g proteins in rat ventricular myocytes, Am J Physiol 259 (1990), H820-H826. (Pubitemid 20310486)
54. M. Kitakaze, T. Minamino, K. Node, Y. Koretsune, K. Komamura, H. Funaya, T. Kuzuya and M. Hori, Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure, Cardiovasc Drugs Ther 12 (1998), 307-309.
55. R.E. Klabunde, Effects of dipyridamole on postischemic vasodilation and extracellular adenosine, Am J Physiol 244 (1983), H273-H280.
56. R.A. Kloner, C.E. Ganote and R.B. Jennings, The "no-reflow" phenomenon after temporary coronary occlusion in the dog, J Clin Invest 54 (1974), 1496-1508.
57. R.A. Kloner, F. Giacomelli, K.J. Alker, S.L. Hale, R. Matthews and S. Bellows, Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion, Circulation 84 (1991), 1758-1772.
58. W. Koenig and E. Ernst, The possible role of hemorheology in atherothrombogenesis, Atherosclerosis 94 (1992), 93-107.
59. A. Koshkaryev, D.K. Kaul, G. Barshtein and S. Yedgar, Vascular resistance induced by oxidized red blood cells with enhanced adherence to endothelium, in: 8th World Congress for Microcirculation, Monduzzi Editore International Proceedings Division, Milwaukee, Wisconsin, USA, 2007, 38-42.
60. C. Kusmic, C. Petersen, E. Picano, C. Busceti, G. Parenti, F.L. Pasini and R. Barsacchi, Antioxidant effect of oral dipyridamole during cerebral hypoperfusion with human carotid endarterectomy, J Cardiovasc Pharmacol 36 (2000), 141-145.
61. A.R. Lankford, J.N. Yang, R. Rose'Meyer, B.A. French, G.P. Matherne, B.B. Fredholm and Z. Yang, Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning, Am J Physiol Heart Circ Physiol 290 (2006), H1469-H1473.
62. H. Leonhardt, H.R. Arntz and U.H. Klemens, Studies of plasma viscosity in primary hyperlipoproteinaemia, Atherosclerosis 28 (1977), 29-40.
63. G.S. Liu, J. Thornton, D.M. Van Winkle, A.W. Stanley, R.A. Olsson and J.M. Downey, Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart, Circulation 84 (1991), 350-356.
64. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M.F. DiCarli, M.A. Leesar, K.F. Browne, P.R. Eisenberg, R. Bolli, A.C. Casas, V. Molina-Viamonte, C. Orlandi, R. Blevins, R.J. Gibbons, R.M. Califf and C.B. Granger, Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The acute myocardial infarction study of adenosine (amistad) trial, J Am Coll Cardiol 34 (1999), 1711-1720.
65. G. Majno, A. Ames 3rd, C.J. and R.L. Wright, No reflow after cerebral ischemia, Lancet 2 (1967), 569-570.
66. L.H. Manciet, D.C. Poole, P.F. McDonagh, J.G. Copeland and O. Mathieu-Costello, Microvascular compression during myocardial ischemia: Mechanistic basis for no-reflow phenomenon, Am J Physiol 266 (1994), H1541-H1550.
67. P.R. Maroko and E. Braunwald, Modification of myocardial infarction size after coronary occlusion, Ann Intern Med 79 (1973), 720-733.
68. M. Marzilli, E. Orsini, P. Marraccini and R. Testa, Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction, Circulation 101 (2000), 2154-2159.
69. K. Matsumura, R.W. Jeremy, J. Schaper and L.C. Becker, Progression of myocardial necrosis during reperfusion of ischemic myocardium, Circulation 97 (1998), 795-804.
70. C.E. Murry, R.B. Jennings and K.A. Reimer, Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium, Circulation 74 (1986), 1124-1136.
71. M. Nakamura, N.P. Wang, Z.Q. Zhao, J.N. Wilcox, V. Thourani, R.A. Guyton and J. Vinten-Johansen, Preconditioning decreases bax expression, PMN accumulation and apoptosis in reperfused rat heart, Cardiovasc Res 45 (2000), 661-670.
72. F. Nappo, N. De Rosa, R. Marfella, D. De Lucia, D. Ingrosso, A.F. Perna, B. Farzati and D. Giugliano, Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins, JAMA 281 (1999), 2113-2118.
73. B. Olafsson, M.B. Forman, D.W. Puett, A. Pou, C.U. Cates, G.C. Friesinger and R. Virmani, Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon, Circulation 76 (1987), 1135-1145.
74. O. Oldenburg, Q. Qin, T. Krieg, X.M. Yang, S. Philipp, S.D. Critz, M.V. Cohen and J.M. Downey, Bradykinin induces mitochondrial ROS generation via NO, CGMP, PKG, and mitokatp channel opening and leads to cardioprotection, Am J Physiol Heart Circ Physiol 286 (2004), H468-H476.
75. C. Penna, D. Mancardi, R. Rastaldo, G. Losano and P. Pagliaro, Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling, Cardiovasc Res 75 (2007), 168-177.
76. K. Przyklenk and R.A. Kloner, "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow, Circ Res 64 (1989), 86-96.
77. K. Przyklenk and P. Whittaker, Brief antecedent ischemia enhances recombinant tissue plasminogen activator-induced coronary thrombolysis by adenosine-mediated mechanism, Circulation 102 (2000), 88-95.
78. H. Relevy, A. Koshkaryev, N. Manny, S. Yedgar and G. Barshtein, Blood banking-induced alteration of red blood cell flow properties, Transfusion 48 (2008), 136-146.
79. J.M. Reynolds and P.F. McDonagh, Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance, Am J Physiol 256 (1989), H982-H989.
80. N.P. Riksen, W.J. Oyen, B.P. Ramakers, P.H. Van den Broek, R. Engbersen, O.C. Boerman, P. Smits and G.A. Rongen, Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans, Clin Pharmacol Ther 78 (2005), 52-59.
81. R. Rosenson, Viscosity and ischemic heart disease, J Vasc Med Biol 4 (1993), 206-212.
82. R.S. Rosenson, Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity, Microcirculation 15 (2008), 615-620.
83. A.R. Saniabadi, T.C. Fisher, C.S. Lau, A. Bridges, J. Taylor, J. Belch and C.D. Forbes, Dipyridamole increases human red blood cell deformability, Eur J Clin Pharmacol 42 (1992), 651-654.
84. A.H. Seplowitz, S. Chien and F.R. Smith, Effects of lipoproteins on plasma viscosity, Atherosclerosis 38 (1981), 89-95.
85. P.A. Southorn and G. Powis, Free radicals in medicine. Ii. Involvement in human disease, Mayo Clin Proc 63 (1988), 390-408.
86. L.M. Snyder, N.L. Fortier, J. Trainor, J. Jacobs, L. Leb, B. Lubin, D. Chiu, S. Shohet and N. Mohandas, Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking, J Clin Invest 76 (1985), 1971-1977.
87. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, I. L'Huillier, J.F. Aupetit, E. Bonnefoy, G.Finet, X. Andre-Fouet and M. Ovize, Postconditioning the human heart, Circulation 112 (2005), 2143-2148.
88. B.E. Strauer, U.E. Heidland, M.P. Heintzen and B. Schwartzkopff, Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: Impact on hemodynamic function and left ventricular performance, J Am Coll Cardiol 28 (1996), 1119-1126.
89. H.Y. Sun, N.P. Wang, M. Halkos, F. Kerendi, H. Kin, R.A. Guyton, J. Vinten-Johansen and Z.Q. Zhao, Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways, Apoptosis 11 (2006), 1583-1593.
90. V.H. Thourani, M. Nakamura, I.G. Duarte, B.L. Bufkin, Z.Q. Zhao, J.E. Jordan, S.T. Shearer, R.A. Guyton and J. Vinten- Johansen, Ischemic preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass grafting, J Thorac Cardiovasc Surg 117 (1999), 383-389.
91. S. Tsukita and H. Ishikawa, Cytoskeletal network underlying the human erythrocyte membrane. Thin-section electron microscopy, J Cell Biol 85 (1980), 567-576.
92. H.C.Wang, H.F. Zhang,W.Y. Guo, H. Su, K.R. Zhang, Q.X. Li,W.Yan, X.L. Ma, B.L. Lopez, T.A. Christopher and F. Gao, Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: Role of peroxynitrite formation, Apoptosis 11 (2006), 1453-1460.
93. H. Watanabe, A. Kobayashi, T. Yamamoto, S. Suzuki, H. Hayashi and N. Yamazaki, Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium, Free Radic Biol Med 8 (1990), 507-514.
94. S.J.Weiss, The role of superoxide in the destruction of erythrocyte targets by human neutrophils, J Biol Chem 255 (1980), 9912-9917.
95. C.R. Welbourn, G. Goldman, I.S. Paterson, C.R. Valeri, D. Shepro and H.B. Hechtman, Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil, Br J Surg 78 (1991), 651-655.
96. R. Wells, Microcirculation and coronary blood flow, Am J Cardiol 29 (1972), 847-850.
97. A.S. Weyrich, M.M. Denis, J.R. Kuhlmann-Eyre, E.D. Spencer, D.A. Dixon, G.K. Marathe, T.M. McIntyre, G.A. Zimmerman and S.M. Prescott, Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates, Circulation 111 (2005), 633-642.
98. S. Wolfrum, A. Dendorfer, M. Schutt, B. Weidtmann, A. Heep, K. Tempel, H.H. Klein, P. Dominiak and G. Richardt, Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/AKT pathway, J Cardiovasc Pharmacol 44 (2004), 348-355.
99. Y. Ye, Y. Lin, R. Perez-Polo, M.H. Huang, M.G. Hughes, D.J. McAdoo, S. Manickavasagam, B.F. Uretsky and Y. Birnbaum, Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination, Am J Physiol Heart Circ Physiol 293 (2007), H813-H818.
100. S. Yedgar, A. Koshkaryev and G. Barshtein, The red blood cell in vascular occlusion, Pathophysiol Haemost Thromb 32 (2002), 263-268.
101. C.K. Zarins, D.P. Giddens, B.K. Bharadvaj, V.S. Sottiurai, R.F. Mabon and S. Glagov, Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress, Circ Res 53 (1983), 502-514.
102. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P.Wang, R.A. Guyton and J. Vinten-Johansen, Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning, Am J Physiol Heart Circ Physiol 285 (2003), H579-H588.
103. L. Zhao, L. Gray, J. Leonardi-Bee, C.S. Weaver, S. Heptinstall and P.M. Bath, Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke, Platelets 17 (2006), 100-104.